Prudential Financial’s Day One Biopharmaceuticals DAWN Stock Holding History

Prudential Financial’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$263K	Buy	+12,260	New	+$173K	﹤0.01%	2059
2025 Q3	–	Sell	-10,682	Closed	-$69.4K	–	2450
2025 Q2	$69.4K	Buy	+10,682	New	+$73.5K	﹤0.01%	2316
2024 Q3	–	Sell	-22,592	Closed	-$311K	–	2728
2024 Q2	$311K	Sell	22,592 -146,930	-87%	-$2.15M	﹤0.01%	2338
2024 Q1	$2.8M	Buy	+169,522	New	+$2.54M	﹤0.01%	1249
2022 Q4	–	Sell	-38,315	Closed	-$767K	–	2609
2022 Q3	$767K	Buy	+38,315	New	+$815K	﹤0.01%	1880
2022 Q1	–	Sell	-13,935	Closed	-$235K	–	2624
2021 Q4	$235K	Buy	+13,935	New	+$286K	﹤0.01%	2488

Other funds holding DAWN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Prudential Financial's DAWN Position: Q1 2026 in Review

Prudential Financial opened a new position in Day One Biopharmaceuticals (DAWN) in Q1 2026: 12,260 shares worth $263K. The stake represents ﹤0.01% of the portfolio and ranks #2059 among its holdings. This is a return to the name: Prudential Financial previously reported a position in DAWN as recently as Q2 2025.

Prudential Financial first reported a position in DAWN in Q4 2021 and has held it in 6 quarters since. The position peaked at $2.8M in Q1 2024. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

Prudential Financial held 12,260 shares of Day One Biopharmaceuticals worth $263K as of Q1 2026.
Day One Biopharmaceuticals was a new Prudential Financial position in Q1 2026.
Day One Biopharmaceuticals made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #2059 holding.
Prudential Financial first reported a position in Day One Biopharmaceuticals in Q4 2021 and has held it in 6 quarters since.
Prudential Financial's Day One Biopharmaceuticals position peaked at $2.8M in Q1 2024.
206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.